Previous Close | 69.30 |
Open | 72.17 |
Bid | 72.74 x 200 |
Ask | 91.05 x 200 |
Day's Range | 70.81 - 74.00 |
52 Week Range | 21.92 - 80.53 |
Volume | |
Avg. Volume | 1,725,047 |
Market Cap | 13.035B |
Beta (5Y Monthly) | 1.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -5.55 |
Earnings Date | Oct 31, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 89.10 |
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:
Review Insmed's (INSM) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.